Literature DB >> 12388614

Delayed mesolimbic system alteration in a developmental animal model of schizophrenia.

Yukiori Goto1, Patricio O'Donnell.   

Abstract

Pharmacological and imaging studies indicate that the prefrontal cortex and nucleus accumbens and their dopamine innervation are central elements of the pathophysiology of schizophrenia. Although symptoms typically appear in young adults, a developmental component has been suggested, primarily in the hippocampus. A neonatal hippocampal lesion in rats and monkeys produces changes resembling schizophrenia symptoms only after the animals reach adulthood, indicating that this procedure could be used as a developmental animal model of this disorder. Here, we explored whether the dopamine projection to the nucleus accumbens becomes functionally altered in these animals. In vivo intracellular recordings revealed abnormal responses in accumbens neurons to activation of their dopamine afferents in adult but not prepubertal animals with a neonatal lesion. This alteration was absent after antipsychotic drug treatment. These results indicate that neonatal hippocampal damage can result in delayed functional deficits in the mesolimbic system, providing a link between the developmental hippocampal deficit and altered dopamine systems postulated to occur in schizophrenia.

Entities:  

Mesh:

Substances:

Year:  2002        PMID: 12388614      PMCID: PMC6757697     

Source DB:  PubMed          Journal:  J Neurosci        ISSN: 0270-6474            Impact factor:   6.167


  43 in total

Review 1.  Memory and socioemotional behavior in monkeys after hippocampal damage incurred in infancy or in adulthood.

Authors:  J Bachevalier; M C Alvarado; L Malkova
Journal:  Biol Psychiatry       Date:  1999-08-01       Impact factor: 13.382

Review 2.  Modulation of cell firing in the nucleus accumbens.

Authors:  P O'Donnell; J Greene; N Pabello; B L Lewis; A A Grace
Journal:  Ann N Y Acad Sci       Date:  1999-06-29       Impact factor: 5.691

Review 3.  Cell biology of the hippocampal formation in schizophrenia.

Authors:  D R Weinberger
Journal:  Biol Psychiatry       Date:  1999-02-15       Impact factor: 13.382

4.  Ventral tegmental area afferents to the prefrontal cortex maintain membrane potential 'up' states in pyramidal neurons via D(1) dopamine receptors.

Authors:  B L Lewis; P O'Donnell
Journal:  Cereb Cortex       Date:  2000-12       Impact factor: 5.357

5.  Long-term effects of neonatal damage to the hippocampal formation and amygdaloid complex on object discrimination and object recognition in rhesus monkeys (Macaca mulatta).

Authors:  J Bachevalier; M Beauregard; M C Alvarado
Journal:  Behav Neurosci       Date:  1999-12       Impact factor: 1.912

6.  The relationship between dorsolateral prefrontal N-acetylaspartate measures and striatal dopamine activity in schizophrenia.

Authors:  A Bertolino; M B Knable; R C Saunders; J H Callicott; B Kolachana; V S Mattay; J Bachevalier; J A Frank; M Egan; D R Weinberger
Journal:  Biol Psychiatry       Date:  1999-03-15       Impact factor: 13.382

Review 7.  The role of endogenous sensitization in the pathophysiology of schizophrenia: implications from recent brain imaging studies.

Authors:  M Laruelle
Journal:  Brain Res Brain Res Rev       Date:  2000-03

8.  GABAergic local circuit neurons and prefrontal cortical dysfunction in schizophrenia.

Authors:  D A Lewis
Journal:  Brain Res Brain Res Rev       Date:  2000-03

9.  Decreased glutamic acid decarboxylase67 messenger RNA expression in a subset of prefrontal cortical gamma-aminobutyric acid neurons in subjects with schizophrenia.

Authors:  D W Volk; M C Austin; J N Pierri; A R Sampson; D A Lewis
Journal:  Arch Gen Psychiatry       Date:  2000-03

Review 10.  To model a psychiatric disorder in animals: schizophrenia as a reality test.

Authors:  B K Lipska; D R Weinberger
Journal:  Neuropsychopharmacology       Date:  2000-09       Impact factor: 7.853

View more
  27 in total

1.  Molecular basis for catecholaminergic neuron diversity.

Authors:  Jan Grimm; Anne Mueller; Franz Hefti; Arnon Rosenthal
Journal:  Proc Natl Acad Sci U S A       Date:  2004-09-07       Impact factor: 11.205

Review 2.  The dynorphin/κ-opioid receptor system and its role in psychiatric disorders.

Authors:  H A Tejeda; T S Shippenberg; R Henriksson
Journal:  Cell Mol Life Sci       Date:  2011-10-16       Impact factor: 9.261

3.  Post-pubertal disruption of medial prefrontal cortical dopamine-glutamate interactions in a developmental animal model of schizophrenia.

Authors:  Kuei-Yuan Tseng; Barbara L Lewis; Barbara K Lipska; Patricio O'Donnell
Journal:  Biol Psychiatry       Date:  2007-01-03       Impact factor: 13.382

4.  Ethanol sensitization in a neurodevelopmental lesion model of schizophrenia in rats.

Authors:  Susan K Conroy; Zachary Rodd; R Andrew Chambers
Journal:  Pharmacol Biochem Behav       Date:  2006-08-28       Impact factor: 3.533

Review 5.  The vulnerability to alcohol and substance abuse in individuals diagnosed with schizophrenia.

Authors:  John H Krystal; D Cyril D'Souza; Jürgen Gallinat; Naomi Driesen; Anissa Abi-Dargham; Ismene Petrakis; Andreas Heinz; Godfrey Pearlson
Journal:  Neurotox Res       Date:  2006-12       Impact factor: 3.911

6.  Olanzapine antipsychotic treatment of adolescent rats causes long term changes in glutamate and GABA levels in the nucleus accumbens.

Authors:  Su Xu; Rao P Gullapalli; Douglas O Frost
Journal:  Schizophr Res       Date:  2014-12-05       Impact factor: 4.939

Review 7.  Limbic and cortical information processing in the nucleus accumbens.

Authors:  Yukiori Goto; Anthony A Grace
Journal:  Trends Neurosci       Date:  2008-09-09       Impact factor: 13.837

8.  Dopamine D2 Modulation of Sign and Goal Tracking in Rats.

Authors:  Juan Carlos Lopez; Rose-Marie Karlsson; Patricio O'Donnell
Journal:  Neuropsychopharmacology       Date:  2015-03-11       Impact factor: 7.853

9.  Bursting activation of prefrontal cortex drives sustained up states in nucleus accumbens spiny neurons in vivo.

Authors:  Aaron J Gruber; Patricio O'Donnell
Journal:  Synapse       Date:  2009-03       Impact factor: 2.562

10.  Disruption of mesolimbic regulation of prefrontal cholinergic transmission in an animal model of schizophrenia and normalization by chronic clozapine treatment.

Authors:  Kathleen S Alexander; Julie M Brooks; Martin Sarter; John P Bruno
Journal:  Neuropsychopharmacology       Date:  2009-08-19       Impact factor: 7.853

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.